Serge Eholié

3.5k total citations
52 papers, 1.2k citations indexed

About

Serge Eholié is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Serge Eholié has authored 52 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Infectious Diseases, 30 papers in Epidemiology and 26 papers in Virology. Recurrent topics in Serge Eholié's work include HIV/AIDS Research and Interventions (30 papers), HIV Research and Treatment (26 papers) and HIV/AIDS drug development and treatment (18 papers). Serge Eholié is often cited by papers focused on HIV/AIDS Research and Interventions (30 papers), HIV Research and Treatment (26 papers) and HIV/AIDS drug development and treatment (18 papers). Serge Eholié collaborates with scholars based in Ivory Coast, France and United States. Serge Eholié's co-authors include Xavier Anglaret, Christine Danel, Delphine Gabillard, Raoul Moh, E. Bissagnené, Eugène Messou, Robert L. Murphy, Stefano Vella, Amani Anzian and Roger Salamon and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Serge Eholié

47 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Serge Eholié Ivory Coast 20 948 556 462 200 162 52 1.2k
Ramu Sarge‐Njie Gambia 21 706 0.7× 634 1.1× 352 0.8× 153 0.8× 98 0.6× 31 1.1k
Maria Franca Pirillo Italy 19 933 1.0× 539 1.0× 378 0.8× 179 0.9× 127 0.8× 58 1.3k
Vadim Pokrovsky Russia 16 1.0k 1.1× 872 1.6× 563 1.2× 190 0.9× 144 0.9× 53 1.4k
Anuvat Roongpisuthipong Thailand 13 854 0.9× 468 0.8× 514 1.1× 177 0.9× 58 0.4× 33 1.1k
David Dalmau Spain 21 970 1.0× 774 1.4× 329 0.7× 333 1.7× 127 0.8× 58 1.4k
Marcelo Losso Argentina 22 995 1.0× 684 1.2× 422 0.9× 253 1.3× 40 0.2× 62 1.4k
José Antonio Iribarren Spain 20 1.1k 1.1× 731 1.3× 593 1.3× 312 1.6× 281 1.7× 84 1.5k
Natasha Press Canada 13 825 0.9× 377 0.7× 431 0.9× 227 1.1× 28 0.2× 25 1.1k
Scott Hammer United States 14 1.3k 1.4× 1.1k 2.0× 280 0.6× 493 2.5× 75 0.5× 23 1.6k
Werner Schimana Tanzania 13 724 0.8× 361 0.6× 254 0.5× 113 0.6× 31 0.2× 25 875

Countries citing papers authored by Serge Eholié

Since Specialization
Citations

This map shows the geographic impact of Serge Eholié's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serge Eholié with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serge Eholié more than expected).

Fields of papers citing papers by Serge Eholié

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Serge Eholié. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serge Eholié. The network helps show where Serge Eholié may publish in the future.

Co-authorship network of co-authors of Serge Eholié

This figure shows the co-authorship network connecting the top 25 collaborators of Serge Eholié. A scholar is included among the top collaborators of Serge Eholié based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Serge Eholié. Serge Eholié is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mohareb, Amir M., Arthur Y. Kim, Anders Boyd, et al.. (2024). Virological, serological and clinical outcomes in chronic hepatitis B virus infection: development and validation of the HEPA-B simulation model. BMJ Open. 14(1). e073498–e073498.
3.
Abraham, G., et al.. (2024). The resurgence of diphtheria in Zinder, Niger. Infectious Diseases Now. 54(8). 104979–104979. 1 indexed citations
4.
5.
Ekouévi, Didier Koumavi, et al.. (2020). HIV self-testing: The key to unlock the first 90 in West and Central Africa. International Journal of Infectious Diseases. 95. 162–166. 13 indexed citations
6.
Ross, Jennifer M., Anani Badjé, Molebogeng X. Rangaka, et al.. (2020). Isoniazid preventive therapy plus antiretroviral therapy for the prevention of tuberculosis: a systematic review and meta-analysis of individual participant data. The Lancet HIV. 8(1). e8–e15. 32 indexed citations
7.
Tchounga, Boris, Charlotte Charpentier, Patrick Coffié, et al.. (2020). Survival among antiretroviral-experienced HIV-2 patients experiencing virologic failure with drug resistance mutations in Cote d’Ivoire West Africa. PLoS ONE. 15(8). e0236642–e0236642. 3 indexed citations
8.
Ouattara, Éric, Christine Danel, Ethan D. Borre, et al.. (2019). Cost-effectiveness and budget impact of immediate antiretroviral therapy initiation for treatment of HIV infection in Côte d’Ivoire: A model-based analysis. PLoS ONE. 14(6). e0219068–e0219068. 10 indexed citations
9.
10.
Balestre, Éric, Didier Koumavi Ekouévi, Boris Tchounga, et al.. (2016). Immunologic response in treatment‐naïve HIV‐2‐infected patients: the IeDEA West Africa cohort. Journal of the International AIDS Society. 19(1). 20044–20044. 9 indexed citations
11.
Beyrer, Chris, Deborah L. Birx, Linda‐Gail Bekker, et al.. (2015). The Vancouver Consensus: antiretroviral medicines, medical evidence, and political will. The Lancet. 386(9993). 505–507. 17 indexed citations
12.
Tchounga, Boris, André Inwoley, Patrick Coffié, et al.. (2014). Re‐testing and misclassification of HIV‐2 and HIV‐1&2 dually reactive patients among the HIV‐2 cohort of The West African Database to evaluate AIDS collaboration. Journal of the International AIDS Society. 17(1). 19064–19064. 19 indexed citations
13.
Ekouévi, Didier Koumavi, Éric Balestre, Patrick Coffié, et al.. (2013). Characteristics of HIV-2 and HIV-1/HIV-2 Dually Seropositive Adults in West Africa Presenting for Care and Antiretroviral Therapy: The IeDEA-West Africa HIV-2 Cohort Study. PLoS ONE. 8(6). e66135–e66135. 32 indexed citations
14.
Vella, Stefano, et al.. (2012). The history of antiretroviral therapy and of its implementation in resource-limited areas of the world. AIDS. 26(10). 1231–1241. 127 indexed citations
15.
Ehui, E., et al.. (2010). Le syndrome de Fanconi induit par le ténofovir en Afrique : deux cas en Côte d’Ivoire. Médecine et Maladies Infectieuses. 41(2). 105–107. 3 indexed citations
16.
Danel, Christine, Delphine Gabillard, André Inwoley, et al.. (2009). Medium-Term Probability of Success of Antiretroviral Treatment after Early Warning Signs of Treatment Failure in West African Adults. AIDS Research and Human Retroviruses. 25(8). 783–793. 7 indexed citations
17.
Moh, Raoul, Christine Danel, Eugène Messou, et al.. (2007). Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa. AIDS. 21(18). 2483–2491. 111 indexed citations
18.
Danel, Christine, Raoul Moh, Amani Anzian, et al.. (2006). Tolerance and Acceptability of an Efavirenz-Based Regimen in 740 Adults (Predominantly Women) in West Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes. 42(1). 29–35. 37 indexed citations
19.
Danel, Christine, Raoul Moh, Albert Minga, et al.. (2006). CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial. The Lancet. 367(9527). 1981–1989. 162 indexed citations
20.
Cheingsong, Rachanee, Thierry H. Roels, Chantal Maurice, et al.. (2001). High Prevalence of Genotypic and Phenotypic HIV-1 Drug-Resistant Strains Among Patients Receiving Antiretroviral Therapy in Abidjan, Côte d'Ivoire. JAIDS Journal of Acquired Immune Deficiency Syndromes. 26(5). 501–506. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ramu Sarge‐Njie Breakdown of academic impact, for papers by Maria Franca Pirillo Breakdown of academic impact, for papers by Vadim Pokrovsky Breakdown of academic impact, for papers by Anuvat Roongpisuthipong Breakdown of academic impact, for papers by David Dalmau Breakdown of academic impact, for papers by Marcelo Losso Breakdown of academic impact, for papers by José Antonio Iribarren Breakdown of academic impact, for papers by Natasha Press Breakdown of academic impact, for papers by Scott Hammer Breakdown of academic impact, for papers by Werner Schimana
Rankless by CCL
2026